Department of Medicine

Clinical Trials Currently in Progress at GILDR

Gastrointestinal

  • Crohn's Disease
  • Ulcerative Colitis
  • Celiac
  • C. difficile
  • Pouchitis

Liver

  • Hepatitis B
  • Hepatitis C
  • Primary Biliary Cirrhosis
  • Alcoholic Hepatitis
  • Nonalcoholic Steatohepatitis
  • Primary Sclerosing Cholangitis
  • Hepatocellular Carcinoma
  • Autoimmune Hepatitis

We have previously performed clinical trials for upper GI bleed, irritable bowel syndrome, dyspepsia, barretts esophagus, colon cancer, colorectal polyps, esophageal cancer, functional dyspepsia, GERD, pancreatitis, & perianal fistulas.

GILDR Group mainly conducts Phase I-Ill clinical trials, which can be double-blinded studies, single-blinded studies, or open label studies.

Prior to participating in a clinical trial the research team will review with study subjects the possible benefits, possible side effects, and frequency and commitment of appointments and will address any concerns the study subject may have about the trial.

To learn more about our studies please contact:

Sharon Appelman-Eszczuk, Director of Operations
GILDR Group
Zeidler Ledcor Centre
8540 - 112 Street
University of Alberta
Edmonton, AB T6G 2X8

Phone (780) 492-8602
Fax (780) 492-8116
Email: sharon.appelman@ualberta.ca